Title : Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control.

Pub. Date : 2003 Jun

PMID : 12766094






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In nateglinide-treated patients, fasting plasma glucose levels decreased by 0.7 mmol/l, 2-h postprandial glucose levels decreased by 2.7 mmol/l, and 30-min insulin levels increased by 165 pmol/l compared with no changes from baseline of these parameters with placebo added to rosiglitazone (P < 0.001). Nateglinide insulin Homo sapiens